QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Reports Q3 Results, 58% Revenue Increase
Predictive Oncology (NASDAQ: POAI), an artificial intelligence (“AI”) and data-driven functional precision medicine company with the mission of improving the standard of care for cancer patients through innovative data-driven products and services, on Friday announced its financial results for the quarter ended September 30, 2019 and provided a business update. Among the highlights, the company reported a 58% year-over-year increase in revenue for the quarter ended September 30, 2019, to $522,696 compared with $329,930 for the same period last year. “I am very pleased with the growth and development of our unique assets, Helomics and Tumor Genesis, and the and…